Clinical Trial Update: Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation [Phase 2]

View source ↗

Summary

Phase 2 intergroup trial evaluating DA-EPOCH-R with Rituximab in children and adolescents with primary mediastinal large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Primary Mediastinal Large B Cell Lymphoma | Phase 2 | Status: COMPLETED